Skip to content
Screener

Viridian Therapeutics, Inc. VRDN Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

PVL
Palvella TherapeuticsPVLA
$528K
Regenxbio logo
RegenxbioRGNX
$43.87M-13.1%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
14.3%+1.7pp
Krystal Biotech, Inc. logo
Krystal Biotech, Inc.KRYS
9.7%+0.1pp
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
10.1%-0.6pp
Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH
$1.52M-60.4%

Other financials

Income statement

See full
Revenue$284.0K+279%
Operating income-$126.3M-18.3%
Net income-$127.1M-26.2%
EPS (diluted)-$1.15-5.5%

Balance sheet

See full
Cash & equivalents$165.0M+40.6%
Total debt$114.4M+395%
Total equity$662.1M+28.5%
Total assets$1.1B+88.4%

Cash flow

See full
Operating cash flow-$105.3M-39.7%
CapEx$1.3M+3,010%
Free cash flow-$106.6M-41.4%

Valuation

See full
Market cap$2.61B+89.4%
Enterprise value$2.56B+99.4%
P/S36.7×-4,485×

Profitability

See full
Gross margin36.3%
Operating margin-569.7%-284pp
Net margin-544.1%-271pp
FCF margin-471%-235pp

Returns & leverage

See full
Return on equity-65.7%-0.1pp
Debt / equity0.2×+0.1×
Current ratio16.9×+5.9×

Where this comes from

Reported directly by Viridian Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The source filing: Viridian Therapeutics, Inc.’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 7:31 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001590750-26-000018
Line itemJune 30,2026December 31,2025
Prepaid expenses and other current assets24,74019,581
Total current assets1,081,270894,233
Property and equipment, net2,7651,228
Operating lease right-of-use asset2,0852,421
Intangible asset, net10,000
Other assets1,1131,536
Total assets$1,097,233$899,418
Liabilities and Stockholders’ Equity

Item 1. Financial Statements (Unaudited)

FAQ

What is Viridian Therapeutics, Inc.'s operating lease ROU assets?
Viridian Therapeutics, Inc. (VRDN) reported operating lease ROU assets of $2.09M in Q2 2026.
How has Viridian Therapeutics, Inc.'s operating lease ROU assets changed year-over-year?
Viridian Therapeutics, Inc.'s operating lease ROU assets increased by 2241935383.9% year-over-year, from $0.09 to $2.09M.
What is the long-term trend for Viridian Therapeutics, Inc.'s operating lease ROU assets?
Over 5 years (2020 to 2025), Viridian Therapeutics, Inc.'s operating lease ROU assets has grown at a 89.1% compound annual growth rate (CAGR), from $100K to $2.42M.
What does operating lease ROU assets mean?
Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.

Ask your AI about Viridian Therapeutics, Inc.'s operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude